[Form 4] Applovin Corporation Insider Trading Activity

Rhea-AI Filing Summary

Applovin Corp director Eduardo Vivas reported multiple open-market sales of Class A common stock on 08/12/2025. The Form 4 shows a total of 125,000 shares sold across seven transactions with reported weighted-average prices ranging from about $463.12 to $468.64. Following the sales, the filing reports beneficial ownership of Class A shares in the range of 7,283,292.249 to 7,404,926.249 shares (some represented by restricted stock units). The Form 4 was signed by an attorney-in-fact on 08/14/2025 and includes explanations that each reported price is a weighted average of multiple trades and that RSUs represent certain holdings.

Positive

• Complete Section 16 disclosure filed showing transaction details and post-sale beneficial ownership
• Reporting includes explanations that prices are weighted averages and offers to provide per-trade details on request

Negative

• Director sold 125,000 Class A shares across seven transactions on 08/12/2025, reducing his direct holdings
• No explanatory context in the filing (e.g., trading plan or reason for sales) beyond weighted-average pricing statements

Insights

Corporate Governance Expert

TL;DR Director Eduardo Vivas executed multiple open-market sales totaling 125,000 Class A shares; disclosures appear complete and routine.

The Form 4 documents systematic dispositions by a director rather than a single large block sale, with sales executed in multiple trades at progressively higher weighted-average prices between approximately $462.40 and $468.90. The filing notes that certain holdings are RSUs, and provides the reporting mechanics and offers to furnish per-trade detail on request. From a governance perspective the filing meets Section 16 disclosure requirements and provides the necessary explanatory footnotes; no additional corporate-action context is provided in the filing itself.

Securities Analyst

TL;DR Material quantity sold by an insider but the filing contains no operational or financial rationale; disclosure is factual and complete.

Aggregate sales equal 125,000 shares on a single calendar date with reported weighted average prices per reported line between $463.12 and $468.64. The filing lists post-transaction beneficial ownership figures and identifies that some shares are RSUs. The report is a standard Section 16 disclosure and does not include commentary linking the transactions to company performance or pre-existing trading plans within the text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vivas Eduardo

(Last) (First) (Middle)

1100 PAGE MILL ROAD

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AppLovin Corp [ APP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/12/2025		S		3,366	D	$463.12(1)	7,404,926.249(2)	D
Class A Common Stock	08/12/2025		S		9,183	D	$463.79(3)	7,395,743.249(2)	D
Class A Common Stock	08/12/2025		S		17,504	D	$465.15(4)	7,378,239.249(2)	D
Class A Common Stock	08/12/2025		S		53,520	D	$466(5)	7,324,719.249(2)	D
Class A Common Stock	08/12/2025		S		30,925	D	$466.74(6)	7,293,794.249(2)	D
Class A Common Stock	08/12/2025		S		8,122	D	$467.93(7)	7,285,672.249(2)	D
Class A Common Stock	08/12/2025		S		2,380	D	$468.64(8)	7,283,292.249(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales were executed in multiple trades at prices ranging from $462.40 to $463.39. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

2. Certain of these securities are represented by Restricted Stock Units ("RSUs").

3. The sales were executed in multiple trades at prices ranging from $463.40 to $464.38. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

4. The sales were executed in multiple trades at prices ranging from $464.42 to $465.41. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

5. The sales were executed in multiple trades at prices ranging from $465.42 to $466.415. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

6. The sales were executed in multiple trades at prices ranging from $466.42 to $467.41. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

7. The sales were executed in multiple trades at prices ranging from $467.42 to $468.41. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

8. The sales were executed in multiple trades at prices ranging from $468.42 to $468.895. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Remarks:

	/s/ Victoria Valenzuela, Attorney-in-fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Applovin (APP) shares did Eduardo Vivas sell on 08/12/2025?

The Form 4 reports an aggregate sale of 125,000 Class A shares by Eduardo Vivas on 08/12/2025.

At what prices were the APP shares sold according to the Form 4?

The reported weighted-average prices by reported line range from $463.12 to $468.64, with underlying per-trade ranges noted between about $462.40 and $468.895.

What was Eduardo Vivas' beneficial ownership of APP Class A shares after the sales?

Post-transaction beneficial ownership reported on the Form 4 ranges by line from 7,283,292.249 to 7,404,926.249 Class A shares; some holdings are represented by RSUs.

Does the Form 4 state whether the sales were part of a 10b5-1 trading plan?

The Form 4 content provided does not state that the sales were made pursuant to a 10b5-1 plan; no such plan is referenced in the filing text supplied.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Victoria Valenzuela, Attorney-in-fact on 08/14/2025.